Evidence map›Paper›PMID 24413686›Full record

ArticleEuropean journal of clinical pharmacology2014

Time to ensure that clinical trial appropriate results are actually published.

Rafael Dal-Ré, Arthur L Caplan

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. No One Likes a Snitch.Science and engineering ethics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Rafael Dal-RéClinical Research Program, Pasqual Maragall Foundation, Barcelona, Spain, rfdalre@gmail.com.
Arthur L Caplan
NYU Langone Health · USPasqual Maragall Foundation · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOutcome reporting bias is a well-known fact in clinical research. It's critical since readers believe that published articles are reliable and accurate.

methodsThe need for investigators to register the trials at the start have made it possible to compare the content of the published article with the registered information.

resultsNearly one-third of clinical trials have changed their primary outcome from the time of registration to publication.

conclusionsEditors should implement measures aimed at preventing outcome reporting bias. To this end, it is proposed that authors, when submitting a manuscript to a journal, should also submit all trial information they have posted on a registry. Authors should comment on the accuracy and completeness of the information provided in the manuscript with respect to that included on the registry. Peer review should only start after the editorial staff has checked the accuracy of the manuscript content with the trial's registered information. This straightforward, although admittedly somewhat demanding exercise for editorial staff, will help ensure the accuracy of published articles and, hence, reduce outcome reporting bias.

Indexed as

Clinical Trials as TopicPublication BiasPublishingHumansRegistriesTreatment Outcome

Identifiers

PMID24413686
OpenAlexW2051484952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.